Carsten Rudolph
Managing Director & Chief Executive Officer Ethris GmbH
Seminars
Tuesday 15th September 2026
Restoring Antiviral Defence With Interferon Lambda to Prevent Virus Driven Respiratory Exacerbations
11:00 am
- How inhaled mRNA delivery of interferon lambda restores epithelial host resistance to reduce virus driven exacerbations in chronic lung disease
- Why targeting interferon lambda upstream of inflammation offers a new preventative strategy beyond bronchodilators biologics and steroids
- What early clinical data show including phase 2a asthma results demonstrating safety, target engagement and the potential to translate this approach into COPD
